Nicotinamide Mononucleotide (NMN)
NAD+ precursor
NMN is involved in pathways that can contribute to NAD+ production. Much of the broader healthy-ageing discussion comes from laboratory and animal research, while human trials are smaller and more limited in duration.
- Biomarker changes should not be treated as proof of longer life or disease prevention.
- Results can depend on dose, formulation, population and study design.
- Product purity or identity should be checked against the testing document for the relevant batch.